Sign in

You're signed outSign in or to get full access.

Ellen Alberding

About Ellen Alberding

Independent director of PGIM Global High Yield Fund, Inc. (GHY) since September 2013; born 1958. Former President and CEO of The Joyce Foundation (2002–2024), with 30+ years in the nonprofit sector and oversight of multiple investment managers; prior trustee of Aon Funds (2000–2003). Serves across a large PGIM fund complex (portfolios overseen rose from 100 to 103) and is designated an Independent Director under the 1940 Act .

Past Roles

OrganizationRoleTenureCommittees/Impact
The Joyce FoundationPresident & CEO2002–2024Led charitable foundation; oversaw multiple investment managers
City Colleges of ChicagoVice Chair2011–2015Governance of community college system
National Park FoundationTrustee2009–2018Governance for national park system charitable foundation
Economic Club of ChicagoTrustee2009–2016Economic policy forum governance
Aon FundsTrustee2000–2003Investment fund board experience

External Roles

OrganizationRoleTenureNotes
Loyola UniversityTrustee2018–PresentHigher education board governance
Public company boardsNoneNo other SEC-reporting company directorships in past five years

Board Governance

  • Independence: Classified as an Independent Director (not an “interested person”) under the 1940 Act .
  • Tenure: Joined GHY Board in September 2013 .
  • Committees: Member, Nominating & Governance; Member, Dryden Investment; no chair roles. Committee structures and charters available on the fund website .
  • Attendance: 100% attendance at Board and assigned committee meetings in FY ended July 31, 2024; Board met eight times in FY2024 (seven times in FY2023) .
  • Board leadership: Board chaired by Independent Director; Independent Directors retain independent legal counsel .
  • Portfolios overseen: 103 in 2025 proxy (100 in 2024 proxy), evidencing broad complex-level responsibilities .

Fixed Compensation

MetricFY 2023FY 2024
Aggregate Fiscal Year Compensation from GHY (cash)$2,003 $1,950
Total Compensation from PGIM Fund Complex (calendar year)$314,000 (30/100 portfolios) $323,000 (32/104 portfolios)
Deferred Fees (calendar year)$290,950 deferred $289,370 deferred
  • Fee deferral program: Independent Directors may defer fees; accrual earns interest at 90-day U.S. Treasury Bill rate each quarter or tracks a selected PGIM mutual fund’s daily return; obligations are general obligations of the Fund; deferred amounts are deposited into a trust for participating Board Members and are not continuing obligations of the Fund .
  • Committee service: Independent Directors serving on committees may receive additional compensation; specific per-committee rates not disclosed .

Performance Compensation

ElementDisclosure
Bonus/variable cashNot disclosed for Independent Directors; compensation presented as fixed fees
Stock awards (RSUs/PSUs)Not applicable/disclosed for Independent Directors
OptionsNot applicable/disclosed for Independent Directors
Performance metrics (EBITDA, TSR, ESG, etc.)None disclosed for director pay
Clawbacks, severance, CoC termsNot disclosed for directors

Other Directorships & Interlocks

CompanyRoleInterlock/Conflict Indicator
NoneNo public company boards in past five years; reduces interlock/conflict risk

Expertise & Qualifications

  • Nonprofit executive leadership with oversight of external investment managers; prior investment fund board experience (Aon Funds) .
  • Board qualification narrative cites ability to critically evaluate information, interact with service providers, and apply business judgment; experience complements Board composition .

Equity Ownership

Holding CategoryGHY Dollar RangeAggregate Dollar Range across PGIM Complex
Independent Director Share OwnershipNone Over $100,000
  • Related-party securities: As of Dec 31, 2024 (and Dec 31, 2023), none of the Independent Directors or their immediate family beneficially owned any securities of the investment adviser or principal underwriter, or controlled affiliates; reduces related-party conflict exposure .

Governance Assessment

  • Positives: Independent status, full attendance, engaged membership on Nominating & Governance and Dryden Investment committees, and no related-party beneficial ownership reduce conflict risk and support investor confidence .
  • Alignment considerations: No direct ownership of GHY shares disclosed (“None”), which may be viewed as limited fund-level “skin-in-the-game”; however, she holds over $100,000 across the PGIM complex, and directors in this complex are compensated via fees with optional deferral rather than equity grants .
  • Compensation structure: Stable, fee-based compensation with substantial voluntary deferrals into a trust and low fund-level cash compensation; no performance-linked metrics or equity awards are disclosed—minimizing pay-for-performance distortions but also limiting direct performance alignment at the fund level .
  • Committee workload: Participation on governance and investment review committees (no chair roles) suggests focus on board composition, director education, and performance oversight; committee charters and meeting cadence (3–4 times in FY2024) indicate formalized oversight .
  • Compliance signals: Section 16 filing compliance met; Audit Committee independence affirmed; PwC audit fees modest with zero non-audit fees to adviser/affiliates—supporting oversight quality .

RED FLAGS

  • No GHY share ownership disclosed for Ellen Alberding (alignment concern for “skin-in-the-game”) .